BioGaia AB (BIOGY)
11.50
0.00 (0.00%)
USD |
OTCM |
Jul 02, 16:00
BioGaia Gross Profit Margin (Quarterly): 71.89% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 71.89% |
| December 31, 2023 | 75.69% |
| September 30, 2023 | 74.24% |
| June 30, 2023 | 71.84% |
| March 31, 2023 | 71.76% |
| December 31, 2022 | 75.83% |
| September 30, 2022 | 72.08% |
| June 30, 2022 | 71.49% |
| March 31, 2022 | 71.24% |
| December 31, 2021 | 77.14% |
| September 30, 2021 | 73.55% |
| June 30, 2021 | 74.26% |
| March 31, 2021 | 71.89% |
| December 31, 2020 | 74.60% |
| September 30, 2020 | 67.83% |
| June 30, 2020 | 75.38% |
| March 31, 2020 | 72.76% |
| December 31, 2019 | 74.26% |
| September 30, 2019 | 72.97% |
| June 30, 2019 | 73.51% |
| March 31, 2019 | 72.65% |
| December 31, 2018 | 75.16% |
| September 30, 2018 | 74.76% |
| June 30, 2018 | 75.66% |
| March 31, 2018 | 73.90% |
| Date | Value |
|---|---|
| December 31, 2017 | 77.06% |
| September 30, 2017 | 73.69% |
| June 30, 2017 | 75.40% |
| March 31, 2017 | 74.93% |
| December 31, 2016 | 74.99% |
| September 30, 2016 | 72.42% |
| June 30, 2016 | 71.82% |
| March 31, 2016 | 70.80% |
| December 31, 2015 | 70.28% |
| September 30, 2015 | 67.77% |
| June 30, 2015 | 69.81% |
| March 31, 2015 | 70.46% |
| December 31, 2014 | 62.78% |
| September 30, 2014 | 65.55% |
| June 30, 2014 | 70.68% |
| March 31, 2014 | 83.19% |
| December 31, 2013 | 65.52% |
| September 30, 2013 | 69.50% |
| June 30, 2013 | 70.17% |
| March 31, 2013 | 66.50% |
| December 31, 2012 | 66.43% |
| September 30, 2012 | 68.96% |
| June 30, 2012 | 71.47% |
| March 31, 2012 | 94.76% |
| December 31, 2011 | 69.46% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
67.83%
Minimum
Sep 2020
77.14%
Maximum
Dec 2021
73.19%
Average
72.97%
Median
Sep 2019
Gross Profit Margin (Quarterly) Benchmarks
| Abliva AB | -- |
| Karolinska Development AB | -- |
| Calliditas Therapeutics AB | 95.26% |
| Oncopeptides AB | -- |
| Olink Holding AB | 60.68% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 18.28% |
| Return on Assets | 16.00% |
| Return on Invested Capital | 18.28% |
| Profit Margin (Quarterly) | 32.95% |
| Operating Margin (Quarterly) | 38.72% |
| Return on Net Operating Assets | 76.99% |